Interactions between neurotransmitters that regulate cAMP and intracellular Ca2+ levels in the CNS.
Cooper
D M
DM
University of Colorado Health Sciences Center, Denver.
Caldwell
K K
KK
Perez-Reyes
E
E
Ahlijanian
M K
MK
Schlegel
W
W
D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D019830:Adenosine-5'-(N-ethylcarboxamide); D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002460:Cell Line; D002490:Central Nervous System / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism*; D005910:Glioma; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D007295:Inositol Phosphates / Q000378:metabolism; D008954:Models, Biological; D018377:Neurotransmitter Agents / Q000502:physiology*; D010660:Phenylisopropyladenosine / Q000494:pharmacology; D015398:Signal Transduction; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D007295:Inositol Phosphates; D018377:Neurotransmitter Agents; D010660:Phenylisopropyladenosine; D006165:Guanylyl Imidodiphosphate; D019830:Adenosine-5'-(N-ethylcarboxamide); D014660:Vasoactive Intestinal Peptide; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D000241:Adenosine; D002118:Calcium